We are live on ! Find out more
TECH icon

Bio-Techne

260 hedge funds and large institutions have $3.37B invested in Bio-Techne in 2015 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 99 increasing their positions, 91 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

4% more funds holding

Funds holding: 250260 (+10)

9% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 91

0% more capital invested

Capital invested by funds: $3.36B → $3.37B (+$5.23M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $360K

Holders
260
Holders Change
+10
Holders Change %
+4%
% of All Funds
6.8%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
29
Increased
99
Reduced
91
Closed
18
Calls
Puts
$360K
Net Calls
-$360K
Net Calls Change
-$73K

TECH Hedge Fund Activity: Q4 2015 in Review

260 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2015, worth a combined $3.37B — up 0.16% from $3.36B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TECH positions and 18 closed out — a net gain of 11 holders — while 99 added to existing stakes and 91 trimmed.

The largest buyer was Select Equity Group, adding an estimated $85.6M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $38M.

  • 260 institutional investors held Bio-Techne (TECH) as of Q4 2015, up from 250 in Q3 2015.
  • Funds reported $3.37B of Bio-Techne stock for Q4 2015, up 0.16% quarter-over-quarter.
  • 29 funds opened new Bio-Techne positions in Q4 2015 and 18 closed out, a net change of +11 holders.
  • The largest Bio-Techne buyer in Q4 2015 was Select Equity Group, an estimated $85.6M added.
  • The largest Bio-Techne seller in Q4 2015 was Columbia Wanger Asset Management, an estimated $38M sold.

Based on aggregated 13F filings for Q4 2015.